Astrazeneca Plc (NYSE:AZN – Get Free Report) has received an average rating of “Moderate Buy” from the eighteen analysts that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating on the company. The […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.